Literature DB >> 3346098

Sister chromatid exchanges and chromosomal aberrations in lymphocytes of nurses handling cytostatic agents.

S Benhamou1, J Pot-Deprun, H Sancho-Garnier, I Chouroulinkov.   

Abstract

A cohort study of 29 nurses who constantly handled cytostatic drugs, and 29 controls matched according to sex and age, was carried out between 1983 and 1986. Cytogenetic damage was assessed by sister chromatid exchanges (SCE) and chromosomal aberrations. No significant increase in mean number of SCE was found for nurses (7.37) as compared to matched controls (7.00), whereas a significant excess of SCE (p less than 0.001) was observed for smokers (8.23) as compared to non-smokers (6.75). The number of SCE was studied in relation to the amount and nature of cytostatics handled as well as to the duration of exposure. A significant association (p less than 0.05) was found between individual mean number of SCE and the total number of drugs handled after adjustment for confounding factors. In contrast, the number of SCE was not significantly related to the nature of drugs handled or to the duration of exposure. With regard to chromosomal damage, no significant difference was observed between nurses and controls in gap, break, dicentric and translocation frequencies.

Mesh:

Substances:

Year:  1988        PMID: 3346098     DOI: 10.1002/ijc.2910410305

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  5 in total

Review 1.  Drugs hazardous to healthcare workers. Evaluation of methods for monitoring occupational exposure to cytostatic drugs.

Authors:  P J Sessink; R P Bos
Journal:  Drug Saf       Date:  1999-04       Impact factor: 5.606

Review 2.  The risks of handling cytotoxic drugs. I. Methods of testing exposure.

Authors:  G P Kaijser; W J Underberg; J H Beijnen
Journal:  Pharm Weekbl Sci       Date:  1990-12-14

3.  Evaluation of genotoxic risk of handling cytostatic drugs in clinical pharmacy practice.

Authors:  E P Guinée; G H Beuman; G Hageman; I J Welle; J C Kleinjans
Journal:  Pharm Weekbl Sci       Date:  1991-04-26

4.  Human effect monitoring in cases of occupational exposure to antineoplastic drugs: a method comparison.

Authors:  S Kevekordes; T W Gebel; M Hellwig; W Dames; H Dunkelberg
Journal:  Occup Environ Med       Date:  1998-03       Impact factor: 4.402

5.  Detection of contamination with antineoplastic agents in a hospital pharmacy department.

Authors:  P J Sessink; R B Anzion; P H Van den Broek; R P Bos
Journal:  Pharm Weekbl Sci       Date:  1992-02-21
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.